VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2020 | CORALLEEN: kicking chemo?

Aleix Prat, MD, PhD, Clinical and Provincial Hospital of Barcelona, Barcelona, Spain, discusses the CORALLEEN trial (NCT03248427), which investigated neadjuvant multi-agent chemotherapy or letrozole plus ribociclib in luminal B/HER2-negative breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter